Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pharmaceutical CXO industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Parexel
IQVIA
FUJIFILM Diosynth Biotechnologies
AGC Biologics
MabPlex International
Lonza Group AG
Pharmablock
Pharmaron Inc
WuXi AppTec
Syneos Health
Wuxi Biologics
Avid Bioservices
Tigermed
Asym Chemical
Charles River Laboratories
AbbVie
Catalent
Jiuzhou Pharma
GenScript
Labcorp Drug Development
By Type:
CDMO
CMO
CRO
By Application:
Biotechnology Companies
Pharmaceutical Companies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pharmaceutical CXO Market Overview 2018-2029
-
1.1 China Pharmaceutical CXO Industry Development Overview
-
1.2 China Pharmaceutical CXO Industry Development History
-
1.3 China Pharmaceutical CXO Industry Market Size (2018-2029)
-
1.4 China Pharmaceutical CXO Market Analysis by Type from Production Side
-
1.4.1 China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CDMO (2018-2029)
-
1.4.2 China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CMO (2018-2029)
-
1.4.3 China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CRO (2018-2029)
-
1.5 China Pharmaceutical CXO Market Analysis by Application from Consumption End
-
1.5.1 China Pharmaceutical CXO Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)
-
1.5.2 China Pharmaceutical CXO Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)
-
1.6 China Pharmaceutical CXO Market Analysis by Region
-
1.6.1 North China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
Chapter 2 China Pharmaceutical CXO Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pharmaceutical CXO Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pharmaceutical CXO Market Status and Competition Analysis in 2023
-
2.2.3 China Pharmaceutical CXO Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pharmaceutical CXO Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pharmaceutical CXO Industry Development
Chapter 3 Pharmaceutical CXOIndustry Chain Analysis
-
3.1 Pharmaceutical CXO Industry Chain
-
3.2 Pharmaceutical CXO Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pharmaceutical CXO Market
-
3.3 Pharmaceutical CXO Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pharmaceutical CXO Market
Chapter 4 China Pharmaceutical CXO Market, by Type
-
4.1 China Pharmaceutical CXO Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pharmaceutical CXO Total Production Volume and Growth Rate from Production Side
-
4.5 China Pharmaceutical CXO Production Volume and Growth Rate, by Type
-
4.5.1 China Pharmaceutical CXO Production Volume and Growth Rate of CDMO
-
4.5.2 China Pharmaceutical CXO Production Volume and Growth Rate of CMO
-
4.5.3 China Pharmaceutical CXO Production Volume and Growth Rate of CRO
Chapter 5 China Pharmaceutical CXO Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pharmaceutical CXO Total Market Size and Growth Rate from Consumption End
-
5.5 China Pharmaceutical CXO Market Size and Growth Rate, by Application
-
5.5.1 China Pharmaceutical CXO Market Size and Growth Rate of Biotechnology Companies
-
5.5.2 China Pharmaceutical CXO Market Size and Growth Rate of Pharmaceutical Companies
Chapter 6 China Pharmaceutical CXO Market, by Region
-
6.1 China Pharmaceutical CXO Production Volume and Production Value, by Region
-
6.2 China Pharmaceutical CXO Sales Volume and Sales Value, by Region
Chapter 7 North China Pharmaceutical CXO Market Analysis
-
7.1 North China Pharmaceutical CXO Market, by Type
-
7.2 North China Pharmaceutical CXO Market, by Application
Chapter 8 Central China Pharmaceutical CXO Market Analysis
-
8.1 Central China Pharmaceutical CXO Market, by Type
-
8.2 Central China Pharmaceutical CXO Market, by Application
Chapter 9 South China Pharmaceutical CXO Market Analysis
-
9.1 South China Pharmaceutical CXO Market, by Type
-
9.2 South China Pharmaceutical CXO Market, by Application
Chapter 10 East China Pharmaceutical CXO Market Analysis
-
10.1 East China Pharmaceutical CXO Market, by Type
-
10.2 East China Pharmaceutical CXO Market, by Application
Chapter 11 Northeast China Pharmaceutical CXO Market Analysis
-
11.1 Northeast China Pharmaceutical CXO Market, by Type
-
11.2 Northeast China Pharmaceutical CXO Market, by Application
Chapter 12 Southwest China Pharmaceutical CXO Market Analysis
-
12.1 Southwest China Pharmaceutical CXO Market, by Type
-
12.2 Southwest China Pharmaceutical CXO Market, by Application
Chapter 13 Northwest China Pharmaceutical CXO Market Analysis
-
13.1 Northwest China Pharmaceutical CXO Market, by Type
-
13.2 Northwest China Pharmaceutical CXO Market, by Application
Chapter 14 Company Profiles
-
14.1 Parexel
-
14.1.1 Parexel Company Profile
-
14.1.2 Parexel Pharmaceutical CXO Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 IQVIA
-
14.2.1 IQVIA Company Profile
-
14.2.2 IQVIA Pharmaceutical CXO Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 FUJIFILM Diosynth Biotechnologies
-
14.3.1 FUJIFILM Diosynth Biotechnologies Company Profile
-
14.3.2 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 AGC Biologics
-
14.4.1 AGC Biologics Company Profile
-
14.4.2 AGC Biologics Pharmaceutical CXO Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 MabPlex International
-
14.5.1 MabPlex International Company Profile
-
14.5.2 MabPlex International Pharmaceutical CXO Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Lonza Group AG
-
14.6.1 Lonza Group AG Company Profile
-
14.6.2 Lonza Group AG Pharmaceutical CXO Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Pharmablock
-
14.7.1 Pharmablock Company Profile
-
14.7.2 Pharmablock Pharmaceutical CXO Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Pharmaron Inc
-
14.8.1 Pharmaron Inc Company Profile
-
14.8.2 Pharmaron Inc Pharmaceutical CXO Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 WuXi AppTec
-
14.9.1 WuXi AppTec Company Profile
-
14.9.2 WuXi AppTec Pharmaceutical CXO Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Syneos Health
-
14.10.1 Syneos Health Company Profile
-
14.10.2 Syneos Health Pharmaceutical CXO Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Wuxi Biologics
-
14.11.1 Wuxi Biologics Company Profile
-
14.11.2 Wuxi Biologics Pharmaceutical CXO Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Avid Bioservices
-
14.12.1 Avid Bioservices Company Profile
-
14.12.2 Avid Bioservices Pharmaceutical CXO Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Tigermed
-
14.13.1 Tigermed Company Profile
-
14.13.2 Tigermed Pharmaceutical CXO Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Asym Chemical
-
14.14.1 Asym Chemical Company Profile
-
14.14.2 Asym Chemical Pharmaceutical CXO Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Charles River Laboratories
-
14.15.1 Charles River Laboratories Company Profile
-
14.15.2 Charles River Laboratories Pharmaceutical CXO Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 AbbVie
-
14.16.1 AbbVie Company Profile
-
14.16.2 AbbVie Pharmaceutical CXO Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Catalent
-
14.17.1 Catalent Company Profile
-
14.17.2 Catalent Pharmaceutical CXO Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Jiuzhou Pharma
-
14.18.1 Jiuzhou Pharma Company Profile
-
14.18.2 Jiuzhou Pharma Pharmaceutical CXO Market Performance
-
14.18.3 Product&Service Introduction
-
14.19 GenScript
-
14.19.1 GenScript Company Profile
-
14.19.2 GenScript Pharmaceutical CXO Market Performance
-
14.19.3 Product&Service Introduction
-
14.20 Labcorp Drug Development
-
14.20.1 Labcorp Drug Development Company Profile
-
14.20.2 Labcorp Drug Development Pharmaceutical CXO Market Performance
-
14.20.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pharmaceutical CXO Industry Research Conclusions
-
15.2 Pharmaceutical CXO Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pharmaceutical CXO Industry Market Size (2018-2029)
-
Figure China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CDMO (2018-2029)
-
Figure China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CMO (2018-2029)
-
Figure China Pharmaceutical CXO Production Volume, Production Value and Growth Rate of CRO (2018-2029)
-
Figure China Pharmaceutical CXO Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)
-
Figure China Pharmaceutical CXO Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)
-
Figure North China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure Central China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure South China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure East China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pharmaceutical CXO Market Size and Growth Rate from 2018-2029
-
Figure Pharmaceutical CXO Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pharmaceutical CXO Market Share by Type in 2018
-
Figure China Pharmaceutical CXO Market Share by Type in 2023
-
Figure China Pharmaceutical CXO Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pharmaceutical CXO Production Volume and Growth Rate of CDMO (2018-2023)
-
Figure China Pharmaceutical CXO Production Volume and Growth Rate of CMO (2018-2023)
-
Figure China Pharmaceutical CXO Production Volume and Growth Rate of CRO (2018-2023)
-
Figure China Pharmaceutical CXO Market Share by Application in 2018
-
Figure China Pharmaceutical CXO Market Share by Application in 2023
-
Figure China Pharmaceutical CXO Total Market Size and Growth Rate from Consumption End
-
Figure China Pharmaceutical CXO Market Size and Growth Rate of Biotechnology Companies (2018-2023)
-
Figure China Pharmaceutical CXO Market Size and Growth Rate of Pharmaceutical Companies (2018-2023)
-
Table China Pharmaceutical CXO Production Volume by Region (2018-2023)
-
Table China Pharmaceutical CXO Production Volume Share by Region (2018-2023)
-
Figure China Pharmaceutical CXO Production Volume Share by Region (2018-2023)
-
Table China Pharmaceutical CXO Production Value by Region (2018-2023)
-
Table China Pharmaceutical CXO Production Value Share by Region (2018-2023)
-
Figure China Pharmaceutical CXO Production Value Share by Region (2018-2023)
-
Table China Pharmaceutical CXO Sales Volume by Region (2018-2023)
-
Table China Pharmaceutical CXO Sales Volume Share by Region (2018-2023)
-
Figure China Pharmaceutical CXO Sales Volume Share by Region (2018-2023)
-
Table China Pharmaceutical CXO Sales Value by Region (2018-2023)
-
Table China Pharmaceutical CXO Sales Value Share by Region (2018-2023)
-
Figure China Pharmaceutical CXO Sales Value Share by Region (2018-2023)
-
Table North China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table North China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure North China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table North China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table North China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure North China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table Central China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table Central China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure Central China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table Central China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table Central China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure Central China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table South China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table South China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure South China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table South China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table South China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure South China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table East China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table East China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure East China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table East China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table East China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure East China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table Northeast China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table Northeast China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table Northeast China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table Southwest China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table Southwest China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table Southwest China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pharmaceutical CXO Production Volume by Type (2018-2023)
-
Table Northwest China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pharmaceutical CXO Production Volume Share by Type (2018-2023)
-
Table Northwest China Pharmaceutical CXO Sales Volume by Application (2018-2023)
-
Table Northwest China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pharmaceutical CXO Sales Volume Share by Application (2018-2023)
-
Table Parexel Company Profile
-
Table Parexel Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table IQVIA Company Profile
-
Table IQVIA Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table FUJIFILM Diosynth Biotechnologies Company Profile
-
Table FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table AGC Biologics Company Profile
-
Table AGC Biologics Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table MabPlex International Company Profile
-
Table MabPlex International Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Lonza Group AG Company Profile
-
Table Lonza Group AG Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Pharmablock Company Profile
-
Table Pharmablock Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Pharmaron Inc Company Profile
-
Table Pharmaron Inc Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table WuXi AppTec Company Profile
-
Table WuXi AppTec Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Syneos Health Company Profile
-
Table Syneos Health Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Wuxi Biologics Company Profile
-
Table Wuxi Biologics Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Avid Bioservices Company Profile
-
Table Avid Bioservices Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Tigermed Company Profile
-
Table Tigermed Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Asym Chemical Company Profile
-
Table Asym Chemical Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Charles River Laboratories Company Profile
-
Table Charles River Laboratories Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Catalent Company Profile
-
Table Catalent Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Jiuzhou Pharma Company Profile
-
Table Jiuzhou Pharma Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table GenScript Company Profile
-
Table GenScript Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
Table Labcorp Drug Development Company Profile
-
Table Labcorp Drug Development Pharmaceutical CXO Revenue, Price and Gross (2018-2023)
-
